HOOKIPA PHARMA INC. (a Delaware corporation) 3,400,000 Shares of Common Stock 2,978 Shares of Series A Convertible Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 2020 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • New York
HOOKIPA Pharma Inc., a Delaware corporation (the “Company”), confirms its agreement with Morgan Stanley & Co. LLC (“Morgan Stanley”) and SVB Leerink LLC (“SVB Leerink”) and each of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Morgan Stanley and SVB Leerink are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of (a) shares of Common Stock, par value $0.0001 per share, of the Company (“Common Stock”) set forth in Schedule A hereto and (b) shares of Series A Convertible Preferred Stock, par value $0.0001 per share, of the Company (“Preferred Stock”) set forth in Schedule A hereto and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the opti
